echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > How much has the national procurement changed the pattern of the pharmaceutical market?

    How much has the national procurement changed the pattern of the pharmaceutical market?

    • Last Update: 2022-01-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Guocai has carried out six batches, but so far there is no analysis of the results from authoritative institutions


    The price of the selected generic drugs has been exchanged for volume, and the volume and price of the unselected generic drugs have fallen.


    Change in sales

    Change in sales

    Compared with one year ago, the procurement volume of the 9 varieties after centralized procurement has increased (2.


    1.


    The purchase volume of the 9 selected generic drugs increased from 4.


    Among them, omeprazole increased the most, from 460 million tablets a year ago to 2.


    2.


    The purchase volume of 9 unselected original research drugs dropped by 46%


    3.


    The purchase volume of 9 unselected generic drugs dropped by as much as 81%


    Changes in the proportion of sales

    Changes in the proportion of sales

    One year after the centralized procurement, the proportion of the procurement of various varieties in the total procurement of the generic name has also changed significantly.


    The proportion of selected generic drug purchases increased by 53%.


    The proportion of purchases of unselected original research drugs decreased by 16%.


    The proportion of unselected generic drug purchases decreased by 37%, the largest decrease was omeprazole, which decreased by 69%, and the smallest decrease was imatinib, which decreased by only 2.


    price change

    price change

    Overall, under the same generic name, the average price of 9 drugs decreased significantly, with an average decrease of 67.


    As far as a single variety is concerned, the price of only one variety has increased (that is, the unselected generic drug omeprazole has increased by 58%), and all the others have declined regardless of whether they are selected or not.


    1.
    Selected generic drugs

    The average purchase price of the selected generic drugs decreased by 82%.
    Among them, the largest decrease was entecavir, which decreased by 90%, and the smallest decrease was imatinib, which only decreased by 22%
    .

    2.
    The original research drug was not selected

    The average purchase price of unselected original research drugs decreased by 13%.
    Among them, the largest decrease was valsartan, which decreased by 21%, and the smallest decrease was aluminum magnesium carbonate chewable tablets, which only decreased by 6.
    5%
    .

    3.
    Unselected generic drugs

    The average purchase price of unselected generic drugs decreased by 34% for entecavir, and the smallest decrease was also for aluminum magnesium carbonate chewable tablets, which decreased by only 3.
    4%
    .

    The purchase price of omeprazole that was not selected was the only one that did not drop but increased, and the increase was as high as 58%
    .
    (Picture 3)

    One year after the centralized procurement of 9 drugs, compared with one year before the centralized procurement, the patent cliff appeared, and the substitution of generic drugs was realized.
    The constraints of the centralized procurement contract ensured a substantial increase in the procurement of selected generic drugs.
    Some companies maintain prices to a certain extent, so that the unselected varieties can temporarily maintain relatively high prices
    .

    In short, the selected generic drugs have realized the exchange of price for the quantity, while the quantity and price of the unselected varieties have fallen.
    Once the price linkage is enforced, the remaining price advantage of the unselected varieties will no longer exist
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.